Graham Capital Management L.P. Buys New Shares in Fate Therapeutics, Inc. (NASDAQ:FATE)
Graham Capital Management L.P. bought a new stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,342 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Other large investors […]
Graham Capital Management L.P. bought a new stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,342 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Other large investors […]
